AI Science Tracker
EN

Deep Learning Radiomics Based on Contrast-Enhanced Ultrasound Might Optimize Curative Treatments for Very-Early or Early-Stage Hepatocellular Carcinoma Patients.

Affiliation not stated in the reviewed material · 31 Mar 2020 · medicine

Discovery

Deep Learning Radiomics Based on Contrast-Enhanced Ultrasound Might Optimize Curative Treatments for Very-Early or Early-Stage Hepatocellular Carcinoma Patients.

Source check: Source checked. Not independent scientific confirmation.

Finding: Cox-CNN radiomics extracted CEUS features to estimate treatment-specific progression-free survival in early HCC and identify candidate treatment-selection differences. Organization is unavailable in the deposited bibliographic metadata.

Technology: CNN-based Cox model for CEUS radiomics and treatment outcomes

Publication: Publication status unspecified in annotation · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
A CNN-based Cox model learned spatiotemporal CEUS features separately for RFA and surgical resection, with radiomics signatures added to nomograms.
Test and result
Cox-CNN radiomics extracted CEUS features to estimate treatment-specific progression-free survival in early HCC and identify candidate treatment-selection differences.
Limitation / still unknown
The reviewed study does not establish validation or benefit beyond its reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://karger.com/lic/article/9/4/397/202376/Deep-Learning-Radiomics-Based-on-Contrast-Enhanced

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.